Tamer I. Khayal, Chief Commercial Officer at TransMedics Group, Inc. (TMDX), sold 35,412 shares at $91.11 ($3.2M) on 2024-04-09, disclosed to the SEC on 2024-04-10.
Scheduled sale ($3.2M) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.00 | 4,388 | $395K | 12.3% |
| 2 | $90.14 | 10,532 | $949K | 29.7% |
| 3 | $90.14 | 10,532 | $949K | 29.7% |
| 4 | $91.11 | 4,980 | $454K | 14.2% |
| 5 | $91.11 | 4,980 | $454K | 14.2% |
| Total | $90.40 avg | 35,412 |
| $3.2M |
| 100% |
| Filing → |
| TMDX | SELL | 2024-12-04 | $187K | — | Filing → |
| TMDX | SELL | 2024-11-13 | $263K | — | Filing → |
| TMDX | SELL | 2024-11-05 | $179K | — | Filing → |